pSivida Corp (NASDAQ:PSDV)

3.94
Delayed Data
As of 10:10am ET
 -0.07 / -1.75%
Today’s Change
3.45
Today|||52-Week Range
4.94
-4.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$117.9M

Company Description

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and BioSilico is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.

Contact Information

pSivida Corp.
400 Pleasant Street
Watertown Massachusetts 02472
P:(617) 926-5000
Investor Relations:

Employees

Shareholders

Mutual fund holders5.60%
Other institutional20.80%
Individual stakeholders2.15%

Top Executives

Paul AshtonPresident, Chief Executive Officer & Director
Marty NazzaroVice President-Operations
Leonard S. RossVP, Chief Financial & Accounting Officer
Hong GuoVice President-Research
Lori H. FreedmanSecretary, VP-Corporate Affairs & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account